You all sites are on hold. We do appreciate stand by. Thank you for standing by. Good morning, ladies and gentlemen. Welcome to the Anton Financial third quarter 2024 earnings conference call. Today's call is being recorded. At this time, all participants have been placed in a listen-only mode. The floor will be open for your questions following the presentation. It is now my pleasure to turn the call over to Aladdin Shalei. You may begin. Thank you.

Before we start, I would like to remind everyone that certain statements made during this conference call may constitute forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical in nature. As described under 1A of our annual report on Form 10-K and Part 2 Item 1A of our quarterly report on Form 10-Q, forward-looking statements are subject to a variety of risks and uncertainties that could cause the company's actual results to differ from its beliefs, expectations, estimates, and projections. Consequently, you should not rely on these forward-looking statements as predictions of future events. Statements made during this conference call are made as of the day of this call, and the company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. I am joined on the call today by Larry Penn, Chief Executive Officer of Ellington Financial, Mark Tecotzky, Co-Chief Investment Officer of EFC, and JR Herlihy, Chief Financial Officer of EFC. As described in our earnings press release, our third quarter earnings conference call presentation is available on our website ellingtonfinancial.com. Management's prepared remarks will track this presentation. Please note any references to figures in this presentation are qualified in their entirety by the notes at the back of the presentation. With that, I will now turn the call over to Larry.

Thanks, Alaael-Deen, and good morning, everyone. As always, thank you for your time and interest in Ellington Financial. I'll begin on slide three of the presentation. Perhaps the highlight of the quarter was the increase in our adjusted distributable earnings to $0.40 per share, which was a $0.07 increase from the second quarter and which covered our $0.39 in dividends for the quarter. The main driver of this quarter's increase in ADE was the contribution from our proprietary reverse mortgage business, our Longbridge segment, which included our second proprietary reverse securitization of the year. Back in the first quarter of this year, ADE in our Longbridge segment was actually negative, but it has increased each quarter since then and it registered $0.12 per share in the third quarter. Our Longbridge segment represents about 12% of our equity capital allocation, so it's great to see ADE having steadily improved in that segment. I consistently highlight our Longbridge segment as holding significant untapped potential for Ellington Financial. Even if Longbridge's ADE can stabilize around $0.09 per share per quarter, we should be in excellent shape from a dividend coverage standpoint. In the third quarter, Ellington Financial's investment portfolio expanded as we utilized our strong balance sheet to continue growing our high-yielding loan portfolios. For the quarter, our non-QM RTL, Commercial Mortgage Bridge, HELOC, and closed-end second lien loan portfolios increased by a combined 26%. That portfolio growth drove our overall leverage a bit higher to 1.8 times from 1.6 times, even as we continue to shrink our lower-yielding agency portfolio and maintain additional dry powder to invest. At quarter-end, our agency portfolio had shrunk another 14% sequentially, and cash plus unencumbered assets totaled $765 million, which was just under 50% of our total equity. Not surprisingly, much of the expansion of our…

We anticipate using some of the proceeds from these financing lines to replace some of our existing higher-cost debt and floating rate preferred equity. For example, we announced yesterday that we are redeeming our Series E preferred stock that we inherited in the Arlington merger, which now carries a cost of funds of well over 10% following its fixed-to-floating rate conversion earlier this year. These types of refinancing should be immediately accretive to earnings, since in the current environment, we see returns on equity on incremental asset acquisitions reaching well into the teens. Meanwhile, with our overall leverage still low, we have additional capacity to issue more long-term unsecured debt and we look forward to doing so. With that, I'll turn the call over to JR to discuss the third quarter financial results in more detail.

Thanks, Larry, and good morning, everyone. For the third quarter, we are reporting GAAP net income of $0.19 per share on a fully mark-to-market basis and adjusted distributable earnings of $0.40 per share. On slide five, you can see the attribution of net income between credit, agency, and Longbridge. The Credit Strategy generated $0.45 per share of net income in the quarter. Including associated financing costs and hedging gains/losses, we had strong net interest income and net gains from non-QM loans and retained tranches, non-agency RMBS, closed-end second lien loans, and CMBS. We also benefited from mark-to-market gains on our equity investments in LendSure and American Heritage Lending, which reflected strong performance at those originators driven by increased volumes and wider origination margins. Offsetting a portion of these gains were net losses on our consumer loan portfolio and a related equity investment in a consumer loan originator, as well as negative operating income on certain non-performing commercial mortgage loans and REO. Finally, we had a net loss on the Great Ajax common shares we purchased in connection with last year's terminated merger. Meanwhile, despite strong results in originations, the Longbridge segment generated a GAAP net loss of $0.03 per share for the third quarter, but this net loss was driven by interest rate hedges as rates fell during the quarter. We had a mark-to-market gain on our HMBS MSR equivalent, but this gain was muted by wider HMBS yield spreads. So the gain didn't keep pace with the net losses on interest rate hedges that we hold against this position. Wider HMBS yield spreads adversely affect the value of the HMBS MSR equivalent because they lower the component of projected service income that stems from the right to fund and securitize future borrower withdrawals. In HECM originations, a decline in…

For our RTL, commercial mortgage, and consumer loan portfolios, we received total principal paydowns of $318 million during the third quarter, which represented 21% of the combined fair value of those portfolios coming into the quarter, as those short-duration portfolios continue to return capital steadily. On slide eight, you can see that our total long agency RMBS portfolio declined by another 14% in the quarter to $395 million. We continue to sell down that portfolio and rotate the capital into higher-yielding opportunities.

In slide nine, it illustrates that our Longbridge portfolio decreased by 5% sequentially to $494 million, driven primarily by the completion of our securitization of prop reverse mortgage loans, partially offset by new proprietary reverse mortgage loan originations during the quarter. Please turn next to slide ten for a summary of our borrowings. On our recourse borrowings, the total weighted average borrowing rate decreased by 21 basis points to 6.77% at September 30th. We continue to benefit from positive carry on our interest rate swap hedges, where we overall receive a higher floating rate and pay a lower fixed rate. The net interest margin on our credit portfolio declined modestly quarter over quarter, while the NIM on agency assets increased. Our recourse debt-to-equity ratio increased to 1.8 to 1 at September 30th, up from 1.6 to 1 at June 30th, primarily driven by an increase in borrowings on our larger credit portfolio, partially offset by a decrease in borrowings on our smaller agency portfolio, proprietary reverse mortgage securitization, which converted certain recourse borrowings to nonrecourse borrowings, and an increase in shareholders' equity. Our overall debt-to-equity ratio ticked up as well to 8.3 to 1 from 8.2 to 1. Since mid-June, we've added three new loan financing facilities that have increased total borrowing capacity by $550 million. As of September 30th, our combined cash and unencumbered assets totaled approximately $765 million, roughly unchanged from June 30th. Our book value per common share was $13.66 at quarter-end, and our total economic return was 0.9% non-annualized for the third quarter. Now over to Mark.

Thanks, JR. This was a strong quarter for EFC. We had a lot of portfolio growth in our core strategies. That portfolio growth, together with strong ADE at Longbridge, helped our ADE cover our dividend, which has been a primary goal of ours. We had solid contributions from our core strategies that should be repeatable. Our origination partners continue to grow their franchises and gain market share, which helped us acquire the loans we like at attractive valuations and at the volumes we've been targeting. The vertical integration of EFC was on full display this quarter. Our non-QM and RTL partners generally grew market share and increased profitability. These greater origination volumes allowed EFC to buy more loans with the credit profiles we seek. EFC's consistent loan pricing then allows our originators to offer more stable pricing to their broker and correspondent relationships, which makes them the counterparty of choice in many cases and helps them grow market share. With the securitization ARB as attractive as it's been this year, our securitization team takes over right after EFC approaches a critical mass of purchased loans. For the quarter, non-agency mortgage bond spreads remained range-bound and much tighter than much of last year. Our securitization team optimizes deal structure based on investor preferences and rating agency feedback. Including the deal that priced last week, we've now completed three securitizations since the end of July: two of non-QM loans and one of prop reverse loans. Securitization serves three important objectives for EFC. Firstly, they allow us to replace short-dated repo with match-funded non-mark-to-market securitization financing that both lowers the cost of financing and reduces the risk of funding hiccups and margin calls. Secondly, by leveraging loans with wide yield spreads with the investment-grade bonds that we sell at tighter yield spreads, we…

And our buying in these sectors has continued at a brisk pace post-quarter-end. Both second liens and HELOCs fit seamlessly into EFC's portfolio as natural complements to our Non-QM loan business. We have secured attractive financing terms so we can finance these loans and pocket a levered NIM. In addition, much like non-QM, we can also securitize these loans, selling investment-grade bonds at terms we believe are more favorable to us than repo and retaining high-yielding tranches for our investment portfolio. Just like non-QM, these securitizations have valuable call features after a lockup period, which gives us the ability to refinance or sell the collateral down the road. Getting back to earnings, not only did our loan strategies have a good quarter, but we also had solid contributions from many of our CUSIP strategies, such as CLOs, CMBS, and other ABS. We also had meaningful contributions from our investments in loan originators. And while it continues to shrink, we also had a strong contribution from our agency MBS portfolio. We did face some headwinds, however. We had some write-downs in our consumer portfolio and a write-down of our investment in the consumer loan originator. But these were one-off events that should be behind us. We continue to work out a few non-performing assets, and although they should not be a continuing drag on GAAP earnings, they will continue to be a modest drag on ADE. Financing terms continue to improve for virtually all our assets, and we continue to expand and broaden our financing relationships. The combination of our steady, stable credit portfolio with a consistent and well-received new issue securitization calendar has resulted in greater appetite among our repo lenders to provide us with repo financing and at more attractive terms. Being able to negotiate better financing terms from…

It's great to see the growth of our adjusted attributable earnings during the third quarter, hand in hand with the continued expansion of our integrated loan origination businesses, which now effectively drive the returns of our investment portfolio. I believe that we've established genuine franchise value in our securitization businesses. Our EFMT shelf has now added two successful proprietary reverse securitizations to the sixteen total non-QM securitizations we have completed since 2017. The performance of our non-QM EFMT securitizations continues to be very strong. We have rightfully earned a long roster of repeat investors in the tranches that we issue. We've also helped our loan originator partners to build significant franchise value themselves as we provide them with capital, help them secure favorable warehouse financing, collaborate with them on credit decisions, and work together with them on strategic initiatives. Ellington Financial benefits not only from high-quality loan flow but in many cases from our pro-rata share of both of their profits as well as the increase in the value of their platforms. Ellington Financial's fourth quarter has started off with a good October. Our credit portfolio grew further during the month in what was a broad-based expansion across sectors. It performed well from both the credit performance and total return perspective. And it benefited from yet another strong execution in the non-QM securitization market. Meanwhile, in our Longbridge segment, prop reverse origination volumes, origination margins, and loan performance were, again, all strong in October. As is our typical practice, later this month, we will be putting out our estimated October month's end book value per share. Finally, I should also add that we were positioned conservatively going into election day from a leverage, liquidity, and interest rate exposure perspective. So the post-election volatility in interest rates has not materially affected us. With that, we'll now open the call up to questions. Operator, please go ahead.

And we will take our first question from Trevor Cranston with Citizens JMP. Please go ahead.

Hi. Thanks. Good morning. There's obviously been some significant moves in interest rates and agency spreads in particular so far in the fourth quarter. Can you guys maybe just give us an update on how you're thinking about relative value between agencies and credit opportunities, how things stand today? Thanks.

Sure. Hey, Trevor. It's Mark. Yeah. You had pretty aggressive spread widening sort of mid-October, towards the end of the month. And in the last four or five days, you've had pretty aggressive spread tightening. So, you know, the reduction in the size of the agency portfolio in EFC, I don't think you should interpret it as a comment on the relative value of agencies versus non-agencies. It's more a process we started a while ago where we want to devote most of the capital to non-agency origination, origination securitization businesses, RTL, our commercial bridge, and so that's been behind the capital rotation. You know, there's certainly times when you get this bounce of spread widening in the agency market, that it offers compelling relative value. But, you know, for EFC, I think what you should expect is a continued decline in the amount of capital allocated to the agency portfolio. It's already very small. And the pace of that decline, I don't think is going to be too impacted by sort of relative volume. And that portfolio is small right now. And we see growing capital needs in some of our loan businesses where we think we can create better longer-term franchise value.

And if I could just add one more thing. One thing on the mortgage basis that you don't really see but it goes on behind the scenes, is that we can be opportunistic and we can vary the extent to which we hedge our non-QM portfolio. As we're accumulating non-QM loans for securitization, for example, or just to hold them, we often, but not always, hedge them with TBA mortgages because they have a lot of the same convexity characteristics, in terms of they prepay faster when rates go down. The prepay is lower and rates go up. Right? So it's and that's something that depending upon our view, on the mortgage business, we can dial up the extent to which we're hedging on non-QMs. With TBAs versus more vanilla instruments like the straight swaps. Yeah. It's a great point. We actually did when we saw that big spread widening. You know, third week of October, we did reduce TBA hedge on the non-QM and moved it to more into swaps. You're at a point in the agency market that if rates stay where they are, origination volumes are gonna be pretty low, you're gonna have a very large treasury calendar. So it's things that are, you know, there's reasons to be constructive on the mortgage basis here for sure.

Yep. Okay. Makes sense. And then, you know, on Longbridge, you guys highlighted it in the prepared comments, the improvement in earnings there, which have been a nice tailwind. And, Larry, you kinda mentioned the nine ten number is, you know, a level that would give you decent dividend coverage. Is that kind of level that's a good baseline to think about if we see more stability in rates and spreads from here? Or any sort of color you can give around kinda what you think about as a baseline contribution from them would be helpful.

Yeah. Sure. Thanks. I have mentioned before that Longbridge's business and being in the reverse mortgage business is definitely rate sensitive. So as rates go up, borrowers can, just because of the way the math works, borrow less against their houses. And vice versa. Rates go down, they can borrow more. So just big picture, they tend to see, I mean, there's seasonal factors, other factors too, but they do the market share, obviously, is gonna factor into it. But they tend to see more origination volume when rates are lower. So we actually have a hedge at Longbridge which makes us money when rates go up to sort of buffer against the fact we expect to see lower volumes and, therefore, lower profits. As rates go up. So you will see volatility there. From an ADE perspective because that hedge is, you know, an interest rate hedge, so it doesn't contribute to ADE. You know, if it's profitable, it's more of a gain or loss, you know, like a capital gain or loss. So yeah. So I think the nine cent number is something that was just, you know, we obviously beat it by three cents or not obviously, but that's what we reported that segment beat it by three cents this quarter. So I'm really just trying to make the point that a, it's achievable. And b, that's kind of a number where, you know, we think we'll be ADE will cover the dividend. In terms of a target, it's not an unreasonable target, but, you know, you will see volatility with rates. And, you know, we did beat it in this quarter. And I think the other thing that I mentioned was that our ability to do securitizations, you know, we've done two so far. That's gonna really help that number too. That was a nice boost. I can't quantify it, but that was a nice boost as well to the ADE. Right? Because it sort of improves the technically, on a sale for accounting purposes, but you can sort of stick with this improves your gain on sale margins in that business. So yeah. So I think from a modeling perspective, I'm not uncomfortable with that as a long-term sort of stabilized value, and, of course, over time, Longbridge, you know, getting into other businesses, you know, prop reverse was not a big business for it. Call it a year ago or eighteen months ago. So you know, there's lots of ways that Longbridge can add ADE in the future even away from its existing business lines.

Got it. Okay. That's helpful. Thank you, guys.

Thank you. And we will take our next question from Bose George with KBW.

Hi. Good morning. This is Frank Gilobetti on for Bose. Wanna start. Can you discuss the competition you're seeing within the non-QM market? And also how has the more active participation from insurance companies impacted that market? Thanks.

Sure. This is Mark. Those are great questions. So Ellington, like most people in the non-QM space, has seen aggressive, consistent buying of non-QM loans from a lot of insurance companies, a lot of them that are fixed annuity sellers. Really, I'd say for the last two and a quarter, two and a half years. So that has been a fixture of the market for a while, I think it's done a couple of things. One is it has stabilized loan prices. So you used to see a lot of volatility in non-QM loan prices. I really about, you know, early in the sell-off in 2022, it was a market that had a lot more price volatility than the agency market, and I think the presence of consistent buying from insurance companies has taken out some of that volatility. So for our originators, I think it's been welcome because they sell to Ellington, but they sell to other buyers as well. It creates competition. Right? The insurance companies have different yield bogeys. A different liability structure. Then you know, an Ellington Financial or an annuity that is really, you know, funding on repo and then doing securitization. So there can be times where the competition from insurance companies can be serious and it really, you know, can push levels around to places where, you know, it doesn't look as attractive as it does at other times. But I'd say for now, it's been sort of a consistent presence that has stabilized the market. It's been a welcome diversifier for our originators. And you also see insurance companies buying the securitization. So I feel like in some ways, they're competitors. In some ways, they're also clients. There's been enough volume to go around. But it's definitely created a different dynamic than what we had, I'd say, pre-COVID when it was not a market where you saw a lot of active insurance company participation.

Thank you. That helps a lot. And then just to move to operating expenses, they're roughly up 18% over the quarter. Can you just discuss what drove that increase and can we expect to see higher OpEx going forward?

Sure. So part of that is we converted, we redeemed, I guess, you could say, options at the Longbridge level. So that's one of the largest drivers of the increase, which is a one-time thing, employee-held options. Thank you. So that's a nonrecurring item that we would not see next quarter in Q4. That's probably the biggest driver.

Thank you.

Thank you. And we will take our next question from Matthew Erdner with Jones Trading. Please go ahead.

Hey, guys. Thanks for taking the question. You talked about your expectation for the pace of securitizations. And then can you speak a little to the execution and how that's been on the reverse?

Well, on the reverse deals, I mean, when you say how it's been, I mean, we're happy with the executions. I'm not sure exactly how you'd like me to elaborate further on that. You know, we've got, you know, it's not as uniform, that space, in terms of the structures that people use in the reverse mortgage space are different. There's not a lot of issuance there. And different issuers use slightly different structures in terms of how the debt is structured. But, you know, we've been very pleased. We've got repeat buyers and we, you know, are accumulating for another deal. And, you know, we think that really helps us having that securitization outlet right, and that long-term locked-in financing out of which a very long-term product, obviously, is something that gives us a lot of confidence to continue to ramp up that origination at Longbridge.

I'm Mariah. I wanna speak to the pace of non-QM securitizations next year. I think, you know, four to six deals is sort of a cadence I would expect us to do. It's gonna depend on origination volumes and deal structures, and there were times where we perceive repo financing is a better way to go, but if the market kinda looks broadly similar to how it is now, I think four to six is where we should be.

Got it. I mean, one thing that we've really tried to build here and have succeeded now is we not only have a diversified portfolio, but we have a really diversified and robust sourcing of all these different loan products. Whether it's Non-QM, RTL. We have many sellers. We're buying a lot of loans each month, and we can dial up or down small balance commercial bridge lending, we're seeing also now increased volume there. So we can dial up and down where we know it's like a faucet, right, in your you turn the faucet a little higher and you get a little more flow, but then, you know, you turn one faucet down and you could turn the other faucet up in different products that we buy. So I think we're in a great place to take advantage of we see the opportunities. You know, we mentioned before that if at some point the insurance, then, you know, on a particular month, let's just say, is so strong that we'd rather take our, you know, turn the faucet down and our non-QM buying, well, you know, we can pick it up in RTL or small balance commercial bridge or just CUSIPs. Right? So I really feel good about the diversity of our sources.

Got it. That's very helpful. And that kinda led into my second question, you know, about where are you guys seeing opportunities right now? I know in the past, you talked about commercial. You just touched on the bridge lending there, but is it just kind of factor of what the market's throwing at you? And then could you expand a little more on what you guys are seeing and plan on doing in the HELOC and second space?

Sure. Yeah. I would say in terms of buying the loans we like, getting to critical mass for securitization, executing the deals, and keeping retained tranches that we expect are gonna have very high yield and the ability, you know, via call options to get loans back in the future. That's a good opportunity for us right now, and we're pursuing that. And it's been that way, you know, last six months for sure. And, you know, I expect that to be the case. We've also seen very good opportunity in CUSIP. I mentioned in my prepared remarks. We had great contributions in some of our non-agency stuff, CRT. We've done well in CMBS. CLO, we mentioned that we shrunk it a little bit because we took gains. So we have a broad platform at Ellington, and the really, I mean, I think a phenomenal suite of PMs. And so we have a lot of different sorta arrows in the quiver. So and I like having some CUSIPs as well as some loans. It's sort of a different return stream. It's nice to sort of get the alpha that you can get from CUSIPs. So and then the second part of your question, second liens in HELOCs. Again, the prepared remarks, to us we think we engage with that product the same way we do with non-QM. It's a high-yielding asset. It has a big spread versus our financing. So just having it on portfolio on a levered basis, you know, with an interest rate hedge on the closed-end seconds, you don't need one on the HELOC, since they're floating off of prime. Prime's kind of been locked to SOFR. So with the appropriate interest rate hedge from time to time, a credit hedge, that gives a nice level of return, but there's also securitization opportunities there. So I would expect us to do a securitization relatively soon on, you know, one or both those products. And follow the same playbook we have for non-QM. Retaining some high-yielding assets, keeping our call rights in place, and replacing repo financing with selling investment-grade bonds that we think, you know, have a lower yield than the yield on the repo. And, you know, we talked about in the prepared remarks, you know, it's match funding. You reduce margin calls. So that's our plan for that product. And it can be, you know, anything we can do in non-QM, we can do that in the HELOCs and then the closed-end seconds. So all that sort of that whole skill set we have and the whole playbook there, it's really transferable.

Yeah. That's great. Thank you for all the color.

Sure. Thank you. And we will take our next question from Eric Hagen with BTIG. Please go ahead.

Hey, thanks. How are you doing? As you retire the preferred and make a move toward more unsecured, is that going to change the optics of your leverage? And is there maybe, like, a change in philosophy around how you manage with the secured leverage and the repo and where that leverage gets applied to certain assets as you retire the pref?

Okay. I'll start out, Eric. Thanks for the question. So I guess, first off, retiring that preferred which is now that it's floating, is well over, you know, over 10% cost of funds. Like, that seems like a no-brainer to us. And it's small. It's $24, $25 million. We have a few different channels to add financing to the balance sheet, secured and unsecured. I mean, on the unsecured side, Larry mentioned that we have, I would say, an appetite to do more. Of course, we need to balance what's the pricing is gonna look like relative to secured financing other options. I mean, when we did our current $210 million deal, a couple of years ago, it was at a spread of 322. And now, you know, recent deals in the mortgage REIT sector have been much wider spreads. Perhaps they're coming in. But the cost of financing on the unsecured is an important consideration. But big picture, we wanna do more. In terms of secured financing, so I mentioned in my prepared remarks that since June, we've added three new facilities secured facilities for loans. That's added $550 million of capacity. We've utilized some, but not all of that. But we have more to draw on new lines. We're expecting to add a new line for the MSRs that we got from Arlington. I think Larry mentioned that as well. Those spreads on those are attractive and between those two sources, we're talking about a few hundred million of additional financing compared to where we were at September 30th. A few other things to think about. We have unencumbered assets on balance sheet of $550 million at quarter-end. The bulk of that are agency and resi loans. And if you do 2:1 leverage on that, you're talking about another couple hundred million of secured financing, available on existing lines. And then we have cash. So we had $220 million of cash at quarter-end and at least some of that, I would consider to be surplus debt. We've been working on deploying in October. And Larry mentioned that the portfolio, the credit portfolio is bigger in October. So, anyway, that was a lot of different pieces, but hopefully, that gets it gets your question.

Yeah. And then I'll just add that from a leverage perspective, with unsecured financing, we're more comfortable increasing the leverage. So I do think that, you know, if we can do one or more unsecured deals, then you'll see our leverage tick up. And then we'd love to know, we'd love to replace just over time. Now this is really more of a longer-term goal. But if we can replace a lot of our short-term repo financing with longer-term financing, that obviously just more just a better company, frankly. So that's something that that's a longer-term aspirational goal. If you look at the mortgage REITs, you know, there's and on the residential mortgage REITs, you know, they don't really haven't been able to pull that off as well, frankly. But that's something that we definitely would have an eye towards long term. But, you know, but short term, we're just looking at, as JR said, some of the, you know, like, the floating rate preferred that now we can replace. And, yes, and that decreases our equity and increases our debts. So, yeah, that's gonna definitely at least show up as an increase in leverage. So we have to, you know, we try to manage for portfolio very conservatively from a liquidity management perspective. So we'll, you know, we'll keep a close eye on that. Right? And this is very stuff, and we are 1.8 times debt equity at September 30th. All those different pieces get us into the low twos, you know, here in the next, you know, quarter or two. And that's probably recourse. Right? Recourse. Yeah. Correct.

Yeah. Great stuff. Appreciate you guys very much.

Thanks, Eric.

Thank you. And we will take our next question from Matthew Howlett with B. Riley. Please go ahead.

Oh, hi everybody. Thanks for taking my question. Just a follow-up on the preferred. I mean, you could replace that preferred, right, with of your other shares, the ATMs and you wanted to at lower cost, we're there a ratio you wanna take down Sorry. Which ATMs?

Yes. Yeah. I mean, look. I think the preferred the new issuance on preferred has been pretty low in our sector in the past couple of years. So we do have ATM facilities on different, you know, common and preferred as you point out. I mean, volumes have been pretty low on preferred. So it doesn't seem like there's a huge at least new it's not exactly what you asked, but a new issue preferred doesn't seem to be there as much as the bank bonds and, you know, other types of unsecured. So it's look. I think that we try to be opportunistic on the capital structure, and that's another potential tool, but volumes and preferred are pretty low and it seems like investor appetite for unsecured is a lot greater than for new as you prefer them. Yeah. And if you and if you look at where it was trading, it would still be expensive. Right? So these Right. The lower one that hasn't the one that's still fixed. Yeah. Right? Is trading at a, you know, a pretty big discount. So I don't I'm not sure if you you know, true. That's not We can't replace that coupon at par. So yeah. So I think that is a better just if we really which we don't wanna do, if we really wanna reduce our, you know, I call it cost of funds, not technically debt. Right? But the comments perspective, it is. So if we really wanna reduce the low, the cost of funds on the common I think we're gonna have to look to replace preferred with, you know, some form of debt, whether it's secured or unsecured.

Right. Gotcha. Because you're always the market leader on low cost before. That's why I asked the question. But if it does open up, I'm sure you'll be back involved. Second question, on the duration of the credit report book, you guys have always been sort of short duration. High yield's short durations. You've always pulled this off time and time again. As you start to invest more in retained tranches, non-QM let me do you wanna take a little more duration on the credit book and then we're on the right cycle, or do you foresee still being, you know, in that, you know, short and intermediate term?

Yeah. I think, you know, non-QM retains trust is there are the, you know, BP subordinated tranches that we retain that are long. But there's also excess IOLs, you know, that's quite short in duration. So I think and then, you know, as you mentioned, the other products are shorter duration products with, you know, it's turnover fast, lot of principal repayments, whether it's RTL, bridge loans, etcetera. So I think all those things being equal. I think we like to stay shorter in duration. But we're not afraid. Like, look. The reverse mortgage space, that's really long duration. So when we our retained tranche is there. So that means I think it depends. Yeah.

I mean, you're picking up great yields. Can you quantify what could be what you could call securitization wise? Next year? I mean, you know, how much was the stuff issued in I'm sure I'm assuming if 2022, 2023, all the stuff they shoot back then could be called if rates, you know, move lower going forward is Yeah. Any client I don't I don't have that at my fingertips. Sorry. But you're right. There's gonna be some deals that's, you know, are gonna pass a lockup period at some point, and I don't know, I don't have that. Yeah. And when we put out our queue early next week, it'll have more information about the existing deals, and we can you can put the pieces together versus, you know, with what's outstanding and then what you can see from Bloomberg in terms of, you know, coupons on the remaining tranches. But we I can point you to use Matt. It's Mark, you know? Yeah. No. I would just say, Matt, it's an interesting point. You did see Verus call a few deals a couple of weeks ago. So, basically, on the non-QM side, the rules are you can call it the earlier of three years, or when the amount of loans in the deal by current face are less than 30% of the, you know, at deal closing. So I think given the prepayment environment we've been in so far, what's gonna come sooner is the three-year date. So anything, you know, 2022 and, you know, when we get to 2025, it's gonna be anything 2022 and earlier, you'll have the right to call them. And you definitely Right. Right. Some of that activity. Yeah.

Right. So some of those deals obviously had very low coupons on them. Yeah. Yeah. We have deals out there where the senior bond had a coupon below 1%. So, you know, we're not calling up. Just gonna be out there. Well, just in terms of the there's gonna be some deals out there that got done with pretty high note rates that are gonna get in the call window soon.

Right. That's interesting. It's upside. It's clearly you guys have the option of doing it. So if spreads remain tight, I'm assuming you'll look at a lot of these deals.

Yeah. I mean, to be fair, and, you know, when we do a deal, we know about the call, and depending on what the note rate is and what the forward curve is, you know, we may ascribe some value to it, we discount that value at a really high discount rate, but so you know, we take it into account. It's not, like, 100% found money, but we've called a bunch of deals in the past. And when we have, it, you know, it's been certainly, you know, a profitable event.

Yep. Great. Well, I look forward to that. We'll look forward to the queue. Last question is, and I've covered Ellington for a long, long time. The company, as it evolves, it's growing, you know, these originators, these stakes and originators growing. And of course, you have Longbridge. Just to clarify, Longbridge is not that's consolidated on the balance sheet. There's no mark to market fair value on Longbridge versus AmeriShore and the others.

Sheet. So we fair value, yeah. We have, yeah. We mark to market the assets that are consolidated on a balance sheet. Those loans, like, we fair value everything else. But, yeah, that's right. There's no, yeah. There's no, yeah. Equity value for the originator. Explicitly on the balance sheet.

So my question for as shareholders, I missed the book. I know you update the $13.60 book. But I mean, when you start to think about the potential value of something like Longbridge or even your other originators, and you look at, you know, where, you know, these other originated Rocket, Penny, Coprara, they're trading way above reported book. And as these businesses grow, I'm assuming they're gonna continue to grow here, I mean, what can you tell investors to let you know, EFC is sort of the $13.66? Hey. We're different than, you know, the books we've given you in over the last decade because we have embedded value in these stakes that, you know, might be worth a lot more in a public or private evaluation setting. I just would love to hear your comments on how investors should look at something like Longbridge.

Right. Well, I think, look. We I think if you look just even recently, right, like I mentioned earlier, that Longbridge had negative AED in the first quarter of this year. Right? So I don't want I think we need to put up some stability there. And like I said before, there's great signs that that's where, you know, if we're not there yet, we're heading there soon. So but you're absolutely right that it would be great. And I think once we can achieve that ability where you can say, okay. There's a and this is really, frankly, more your expertise than ours and more your job than ours, but you would say, okay. So there's a chunk of this company that should be trading in a multiple of earnings, not, you know, a percentage of book value. Right? I mean, that's really, I think, what you're getting at. And absolutely. And I agree with that 100%. And, you know, we said that right now our capital allocation is that earlier our capital allocation longer 12%. But, you know, you can even a high multiple on 12% of the company can have a meaningful impact in your overall euro way you trade overall. But, look, I think it's, you know, for now, it's about covering the dividends, you know, and our ADE covered the dividend in the third quarter, and I think we're, you know, it's I feel good about it.

Yeah. And I was just I think underscoring the point, we talked about nine cents as kind of a stabilized or maybe run rate or target on numbers. That's a lot more than 12% of our dividend. Right? So k. they're 12% of capital. Right? You know, that's 23% of our $0.39.

Yep. So I'm assuming all entities you're hiring and all origination is all hiring now. I'm assuming guys are in growth mode for all these stake ship.

Yeah. You know, everybody's trying to be more efficient.

So I don't know that we're necessarily at, you know, at our originator, whether it's ones that we own stakes in or the ones that we don't or Longbridge, obviously, which is part of us. I don't know if you're gonna see massive hiring. At this point. I think everybody's been able to over the past few years just get a lot more efficient after, you know, rates spiked in 2022. Right? And so I think they've I don't think you're necessarily gonna see a huge amount of hiring there? You might but you might see some, especially as product lines increase, things like that.

Great. Well, I look forward to continue to contribute from Longbridge and the others. Appreciate it.

Absolutely. Thanks, Matt.

Thank you. That was our final question for today. Thank you for participating in the Ellington Financial third quarter 2024 earnings conference. You may disconnect your line at this time, and have a wonderful day.